FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890716402> ?p ?o ?g. }

• W2890716402 endingPage "2308" @default.
• W2890716402 startingPage "2301" @default.
• W2890716402 abstract "Background and Purpose— Atrial fibrillation (AF) is a common arrhythmic disorder among the elderly and sometimes progresses from paroxysmal to sustained (persistent or permanent) types. Clinical outcomes of patients with progression of AF were unknown. This study assessed the characteristics of patients with AF progression and the impact of AF progression on various clinical events. Methods— The Fushimi AF Registry is a community-based prospective survey of the patients with AF in Fushimi-ku, Kyoto. Analyses were performed on 4045 patients, which included 1974 paroxysmal AF (PAF; 48.8%) and 2071 sustained (persistent or permanent) AF (SAF; 51.2%) at baseline. Results— During the median follow-up period of 1105 days, progression of AF occurred in 252 patients with PAF (4.22 per 100 person-years). Multivariate Cox regression analysis demonstrated that progression of AF was significantly associated with an increased risk of ischemic stroke or systemic embolism (adjusted hazard ratio [HR], 4.10; 95% CI, 1.95–8.24; P <0.001 [versus PAF without progression]; adjusted HR, 2.20; 95% CI, 1.11–4.00; P =0.025 [versus SAF]) during progression period from paroxysmal to sustained forms. The risk after the progression was equivalent to SAF (adjusted HR, 1.54; 95% CI, 0.78–2.75; P =0.201 [versus SAF]). AF progression was significantly associated with a higher risk of hospitalization for heart failure (adjusted HR, 2.70; 95% CI, 1.55–4.52; P <0.001 [versus PAF without progression]; adjusted HR, 1.81; 95% CI, 1.08–2.88; P =0.026 [versus SAF]). Conclusions— Progression of AF was associated with increased risk of clinical adverse events during arrhythmia progression period from PAF to SAF among Japanese patients with AF. The risk of adverse events was transiently elevated during progression period from PAF to SAF and declined to the level equivalent to SAF after the progression. Clinical Trial Registration— URL: http://www.umin.ac.jp/ctr/ . Unique identifier: UMIN000005834." @default.
• W2890716402 created "2018-09-27" @default.
• W2890716402 creator A5002029715 @default.
• W2890716402 creator A5002932814 @default.
• W2890716402 creator A5022030714 @default.
• W2890716402 creator A5032003867 @default.
• W2890716402 creator A5035471147 @default.
• W2890716402 creator A5038405190 @default.
• W2890716402 creator A5043193338 @default.
• W2890716402 creator A5045030688 @default.
• W2890716402 creator A5053158912 @default.
• W2890716402 creator A5055581717 @default.
• W2890716402 creator A5072002120 @default.
• W2890716402 creator A5074073864 @default.
• W2890716402 creator A5082103856 @default.
• W2890716402 creator A5083207179 @default.
• W2890716402 creator A5084838947 @default.
• W2890716402 date "2018-10-01" @default.
• W2890716402 modified "2023-10-17" @default.
• W2890716402 title "Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events" @default.
• W2890716402 cites W1537095672 @default.
• W2890716402 cites W1967792178 @default.
• W2890716402 cites W1970242617 @default.
• W2890716402 cites W1983108360 @default.
• W2890716402 cites W1998467777 @default.
• W2890716402 cites W2045829317 @default.
• W2890716402 cites W2059608558 @default.
• W2890716402 cites W2069426721 @default.
• W2890716402 cites W2114518541 @default.
• W2890716402 cites W2116664693 @default.
• W2890716402 cites W2147797899 @default.
• W2890716402 cites W2149166027 @default.
• W2890716402 cites W2152067950 @default.
• W2890716402 cites W2164861810 @default.
• W2890716402 cites W2165141699 @default.
• W2890716402 cites W2174666533 @default.
• W2890716402 cites W2286228684 @default.
• W2890716402 cites W2324628668 @default.
• W2890716402 cites W2509795914 @default.
• W2890716402 cites W2519124963 @default.
• W2890716402 cites W2575766324 @default.
• W2890716402 cites W2589173078 @default.
• W2890716402 cites W2619536148 @default.
• W2890716402 cites W33429426 @default.
• W2890716402 cites W4205645630 @default.
• W2890716402 cites W84608388 @default.
• W2890716402 doi "https://doi.org/10.1161/strokeaha.118.021396" @default.
• W2890716402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30355097" @default.
• W2890716402 hasPublicationYear "2018" @default.
• W2890716402 type Work @default.
• W2890716402 sameAs 2890716402 @default.
• W2890716402 citedByCount "59" @default.
• W2890716402 countsByYear W28907164022018 @default.
• W2890716402 countsByYear W28907164022019 @default.
• W2890716402 countsByYear W28907164022020 @default.
• W2890716402 countsByYear W28907164022021 @default.
• W2890716402 countsByYear W28907164022022 @default.
• W2890716402 countsByYear W28907164022023 @default.
• W2890716402 crossrefType "journal-article" @default.
• W2890716402 hasAuthorship W2890716402A5002029715 @default.
• W2890716402 hasAuthorship W2890716402A5002932814 @default.
• W2890716402 hasAuthorship W2890716402A5022030714 @default.
• W2890716402 hasAuthorship W2890716402A5032003867 @default.
• W2890716402 hasAuthorship W2890716402A5035471147 @default.
• W2890716402 hasAuthorship W2890716402A5038405190 @default.
• W2890716402 hasAuthorship W2890716402A5043193338 @default.
• W2890716402 hasAuthorship W2890716402A5045030688 @default.
• W2890716402 hasAuthorship W2890716402A5053158912 @default.
• W2890716402 hasAuthorship W2890716402A5055581717 @default.
• W2890716402 hasAuthorship W2890716402A5072002120 @default.
• W2890716402 hasAuthorship W2890716402A5074073864 @default.
• W2890716402 hasAuthorship W2890716402A5082103856 @default.
• W2890716402 hasAuthorship W2890716402A5083207179 @default.
• W2890716402 hasAuthorship W2890716402A5084838947 @default.
• W2890716402 hasBestOaLocation W28907164021 @default.
• W2890716402 hasConcept C126322002 @default.
• W2890716402 hasConcept C127413603 @default.
• W2890716402 hasConcept C164705383 @default.
• W2890716402 hasConcept C188816634 @default.
• W2890716402 hasConcept C207103383 @default.
• W2890716402 hasConcept C2778198053 @default.
• W2890716402 hasConcept C2779161974 @default.
• W2890716402 hasConcept C2779668873 @default.
• W2890716402 hasConcept C2780645631 @default.
• W2890716402 hasConcept C44249647 @default.
• W2890716402 hasConcept C50382708 @default.
• W2890716402 hasConcept C71924100 @default.
• W2890716402 hasConcept C78519656 @default.
• W2890716402 hasConceptScore W2890716402C126322002 @default.
• W2890716402 hasConceptScore W2890716402C127413603 @default.
• W2890716402 hasConceptScore W2890716402C164705383 @default.
• W2890716402 hasConceptScore W2890716402C188816634 @default.
• W2890716402 hasConceptScore W2890716402C207103383 @default.
• W2890716402 hasConceptScore W2890716402C2778198053 @default.
• W2890716402 hasConceptScore W2890716402C2779161974 @default.
• W2890716402 hasConceptScore W2890716402C2779668873 @default.
• W2890716402 hasConceptScore W2890716402C2780645631 @default.
• W2890716402 hasConceptScore W2890716402C44249647 @default.

• next